🇮🇳 India 23andMe Exits Drug Development to Step Into Weight-Loss Wave (Bloomberg) — 23andMe Holding Co.’s strategy is shifting as the struggling DNA-testing firm shuts…
Axsome Axsome Stock Dips On Wide Losses Despite 135% Growth For A Key Drug Axsome stock fell Monday after the biotech company posted wider-than-expected losses, though secon…
